Trials (Erasmus MC Kanker Instituut): Revision history

15 December 2025

• curprev 17:1917:19, 15 December 2025‎ Francine talk contribs‎ 11,665 bytes +204‎ No edit summary undo

6 December 2025

• curprev 12:4012:40, 6 December 2025‎ Lucas talk contribs‎ m 11,461 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:3417:34, 4 December 2025‎ Larysse talk contribs‎ 9,760 bytes +56‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 9,704 bytes +90‎ Update categories. undo

5 December 2023

• curprev 18:3418:34, 5 December 2023‎ Francine talk contribs‎ 9,614 bytes +9,614‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Erasmus MC Kanker Instituut page '''NCTID''': NCT05208047 '''Title''': (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors '''Study Summary''': This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 426 patients. Part 1 consist..."